Thorne Healthtech Inc (THRN) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Thorne Healthtech Inc   (NASDAQ: THRN)


Thorne Healthtech Inc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Thorne Healthtech Inc's ROI in the second quarter of 2023?
Thorne Healthtech Inc achieved a return on average invested assets (ROI) of 10.75 % in its second quarter of 2023, this is above THRN's average return on investment of 4.19%.
Thorne Healthtech Inc invested over the 12 months ending in its second quarter of 2023 $184 million

ROI has improved compared to 5.83% in the first quarter of 2023, due to net income growth.

Within the Healthcare sector 104 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2023 quarter, so far to 911, from total ROI ranking in the first quarter of 2023 at 1317.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM 25.5 % 90.08 % 225.27 % 761.26 % -
Y / Y Net Income Change TTM 1297.94 % 41.47 % 598.34 % 556.1 % -
Investment (TTM) in Millions 228 210 162 136 157
Return On Investment (TTM) 10.75 % 5.83 % 9.71 % 2.81 % 0.97 %
THRN's Overall Ranking # 911 # 1317 # 1008 # 2421 # 0
Seq. Investment Change TTM 10.66 % 8.08 % 6.89 % -1.83 % 67.61 %
Seq. Net Income Change TTM 104.22 % -35.11 % 268.56 % 186.22 % -79.33 %
Net Income (TTM) in Millions 20 10 15 4 1

THRN Company Profile >> Back to THRN Roi Comparisons >> See Annual THRN Return On Investment



Return On Investment THRN's Ranking
Within: No.
Industry # 44
Sector # 105
Overall # 911

Return On Investment Statistics
High Average Low
9.25 %
4.19 %
-0.61 %
(Jun 30 2023)  







Financial Statements
Thorne Healthtech Inc's II. Quarter Investments $ 228 Millions THRN's Balance sheet
Thorne Healthtech Inc's II. Quarter Income $ 4 Millions Quarterly THRN's Income Statement
THRN's Income by Division See THRN's Income by Division


THRN Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021


Total Investments in Millions 149 120 0 0 0
Y / Y Investment Growth 24.28 % - - - -
Net Income in Millions 15 7 0 0 0
Y / Y Net Income Growth 118.16 % - - - -
Annual Return On Investment 10 % 5.69 % - - -


Annual Roi Comment
In the fiscal year 2022 ROI improved to 10 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
THRN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for THRN's Competitors
Subscribers only: Roi for Thorne Healthtech Inc's Suppliers
Subscribers only: Return On Investment for THRN's Customers

Other Ratios
THRN's Roa THRN's Inventory Turnover Ratio THRN's Growth Rates THRN's Dividend Statistics
THRN's Profitability Ratios THRN's Asset Turnover Ratio THRN's Dividend Growth
THRN's Roe THRN's Valuation Ratios THRN's Financial Strength Ratios THRN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI
Tao Synergies Inc   29.39 %
Pro dex Inc   26.52 %
Arcturus Therapeutics Holdings Inc   25.44 %
Protalix Biotherapeutics inc   24.37 %
Point Biopharma Global Inc   22.31 %
Vertex Pharmaceuticals Inc  21.55 %
Iradimed Corporation  20.01 %
Eli Lilly And Company  19.95 %
Exicure Inc   19.69 %
Corcept Therapeutics Inc  19.22 %
Innoviva Inc   19.15 %
Escalon Medical Corp   19.10 %
Zoetis Inc   18.60 %
Waters Corporation  18.58 %
Chemed Corporation  18.20 %
Edwards Lifesciences Corporation  18.17 %
Siga Technologies Inc  17.68 %
West Pharmaceutical Services Inc   16.86 %
Regeneron Pharmaceuticals Inc   16.83 %
Resmed Inc   16.52 %
Zynex inc   16.45 %
United Therapeutics Corporation  14.83 %
Omeros Corporation  14.74 %
Ufp Technologies Inc   14.68 %
Hca Healthcare Inc   14.67 %
Utah Medical Products Inc  14.42 %
Halozyme Therapeutics Inc   14.14 %
Bruker Corporation  13.98 %
Precigen Inc   13.84 %
Exelixis Inc   13.55 %

Date modified: 2026-08-29T17:45:27+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.